SHANGHAI, Nov. 17, 2020 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company based in Shanghai, China, announced that, after consulting with the U.S. Food and Drug Administration (FDA), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback